| Assay ID | Title | Year | Journal | Article |
|---|
| AID1347117 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-37 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347118 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for TC32 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347101 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347112 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-12 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1347102 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347089 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347094 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347122 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for U-2 OS cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347127 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Saos-2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347121 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for control Hh wild type fibroblast cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347119 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for MG 63 (6-TG R) cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1347090 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1347113 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for LAN-5 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347124 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for RD cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347107 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347111 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-MC cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347099 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347098 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347104 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347096 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347109 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB1643 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347100 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347116 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SJ-GBM2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347106 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347095 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347105 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347103 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347097 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347114 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for DAOY cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347123 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh41 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347115 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB-EBc1 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347128 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for OHS-50 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347411 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7
| High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
| AID1347110 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for A673 cells) | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347092 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347129 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-SH cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347091 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347126 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh30 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347108 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347125 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh18 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347093 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID258291 | Inhibition of MEK1 activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258297 | Inhibition of PKCalpha activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258287 | Inhibition of JNK1 activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258305 | Selectivity of p38alpha over bRaf | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258300 | Inhibition of p38-alpha MAPK activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258289 | Inhibition of MAPK2 activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258286 | Inhibition of GSK3-beta activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258290 | Inhibition of MAPKAPK2 activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258307 | Selectivity of Lck over bRaf | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258283 | Inhibition of AMPK activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID342340 | Binding affinity to B-Raf by fluorescene ligand binding assay | 2008 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
| The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase. |
| AID568446 | Inhibition of B-Raf V600E mutant | 2011 | Bioorganic & medicinal chemistry letters, Feb-15, Volume: 21, Issue:4
| The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors. |
| AID322453 | Inhibition of Raf1 kinase | 2008 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
| Pharmacophore identification of Raf-1 kinase inhibitors. |
| AID258298 | Inhibition of PRAK activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258292 | Inhibition of MSK1 activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID342345 | Blood clearance in rat | 2008 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
| The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase. |
| AID258301 | Inhibition of p38-beta MAPK activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258299 | Inhibition of ROCK2 activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258294 | Inhibition of phosphorylase kinase activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258303 | Inhibition of p38delta MAPK activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258285 | Inhibition of CK2 activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258281 | Inhibition bRaf kinase activity | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID342342 | Inhibition of B-Raf-mediated ERK phosphorylation in rat PC12 cells at 3 uM pretreated for 60 mins prior to nerve growth factor stimulation | 2008 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
| The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase. |
| AID258295 | Inhibition of PKA activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258282 | Binding affinity at bRaf kinase in fluorescent ligand displacement assay | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID342343 | Neuroprotective activity against oxygen and glucose deprivation-induced cell death in rat hippocampal slices at 10 uM | 2008 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
| The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase. |
| AID258306 | Selectivity of GSK3-beta over bRaf | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258288 | Inhibition of Lck activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID342346 | Ratio of drug level in brain to blood in rat at 1 and 3 mg/kg/h, iv infused to steady-state for 6 to 16 hrs | 2008 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
| The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase. |
| AID258284 | Inhibition of CHK1 activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258304 | Inhibition of SGK activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258302 | Inhibition of p38-gamma MAPK activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258293 | Inhibition of p70S6K activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID258296 | Inhibition of PKBalpha activity at 10 uM | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID1345813 | Human Raf-1 proto-oncogene, serine/threonine kinase (RAF family) | 2008 | Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
| Pharmacophore identification of Raf-1 kinase inhibitors. |
| AID1345687 | Human B-Raf proto-oncogene, serine/threonine kinase (RAF family) | 2006 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
| The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. |
| AID1798626 | Fluorescence Anisoptrophy Kinase Binding Assay from Article 10.1016/j.bmcl.2008.06.070: \\The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.\\ | 2008 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
| The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |